DIAGNOS Announces New Distributor for Indonesia

DIAGNOS inc. (“DIAGNOS” or “the Corporation”) /quotes/comstock/11v!e:adk (CA:ADK 0.42, -0.03, -5.62%) , a leader in the use of artificial intelligence and advanced knowledge extraction techniques, announces today that it has signed a Distribution Agreement to cover Indonesia and part of the United Arab Emirates with Genesis Knowledge Streams Inc.

“We look forward to deploying DIAGNOS CARA health care application in Indonesia and some emirates of the UAE, due to the changing life styles of their rapidly growing middle classes, and their limited public awareness of the serious health threats related to diabetes. The prevalence of diabetes, has reached epidemic levels in many emerging regions of the world, including Indonesia which, according to the World Health Organization, ranks #4 in the world in terms of its overall population of 230 millions, and the 21 millions of Indonesians affected with diabetes, thus positioning Indonesia, after India, China and the USA. In the United Arab Emirates, Diabetes affects an alarming 25% of the local UAE population”

“We have been working with Genesis Knowledge Streams for the last two years and we feel confident that they will be able to deploy our CARA solution in a timely fashion and also with the right targeted customers in these countries. Our target customers include hospitals, diabetes clinics and family health units. Genesis leadership in providing web related solutions for the heath care sector makes them an ideal partner for DIAGNOS. We look forward to growing the delivery of ophthalmology services in Indonesia and United Arab Emirates with our new partnership agreement. Genesis Knowledge Streams will receive a 25% discount on the sales revenue from these countries” said Andre Larente, DIAGNOS’ President.

About Genesis Knowledge Streams
Genesis designs innovations in Social Networking Platforms for professional communities and Fortune Top 1000 Enterprises, to nurture organizational growth, global knowledge sharing and rapid innovations delivered through Software-as-a-Services, Cloud Computing and AI based innovations.

About CARA
CARA is a tele-ophthalmology platform that integrates with existing equipment (hardware and software) and processes at the point of service (POS) and comprises: image upload, automated pre-screening, grading by a specialist and referral to a specialist. CARA’s image enhancement algorithms make standard retinal images sharper, clearer, and easier to read. It is an automated platform accessible securely over the internet, and is compatible with all recognized image formats and brands of fundus cameras. CARA is a cost-effective tool for processing large numbers of images, in real-time and has been issued a licence by Health Canada for commercialization in Canada.

About DIAGNOS
Founded in 1998, DIAGNOS is a publicly traded Canadian corporation with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including natural resources, healthcare, and entertainment.

For further information, please visit our website at http://www.diagnos.com or the SEDAR website at http://www.sedar.com.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this press release.

Contacts:
DIAGNOS Inc.
Investor Relations Representative: Andre Larente
Chief Executive Officer
1-877-678-8882 or 450-678-8882, ext.:  224
.(JavaScript must be enabled to view this email address)

SOURCE: DIAGNOS Inc.